Literature DB >> 7883969

The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role.

S Falzoni1, M Munerati, D Ferrari, S Spisani, S Moretti, F Di Virgilio.   

Abstract

We have investigated responses of human monocyte/macrophage cells to extracellular ATP (ATPe). Freshly isolated peripheral blood monocytes showed responses linked to P2Y but not P2Z purinergic receptors; however, during in vitro macrophage differentiation, these cells also exhibited responses suggestive of the presence of the membrane-permeabilizing P2Z receptor. In fact, in human macrophages a brief (15-min) exposure to ATPe, but not other nucleotides, caused (1) a rapid and long-lasting plasma membrane depolarization; (2) a large increase in intracellular Ca2+ concentration followed by efflux of the Ca2+ indicator; (3) uptake of low molecular weight hydrophilic molecules such as Lucifer yellow and ethidium bromide; and (4) cell rounding, swelling, and eventual release of the cytoplasmic enzyme lactate dehydrogenase. rIFN-gamma enhanced both membrane-permeabilizing and cytotoxic ATPe effects. Membrane permeabilization and cytotoxicity were fully blocked by pretreatment of the cells with oxidized ATP, a compound recently shown to block P2Z receptors covalently in macrophages. Blocking of the P2Z receptor by oxidized ATP also inhibited multinucleated giant cell generation stimulated by concanavalin A or rIFN-gamma without decreasing monocyte migration or membrane adhesion molecule expression. These data suggest that human macrophages express rIFN-gamma-modulated purinergic P2Z receptors in vitro and hint at a role for these plasma membrane molecules in the generation of macrophage polykarions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7883969      PMCID: PMC441459          DOI: 10.1172/JCI117770

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Extracellular ATP perturbs transmembrane ion fluxes, elevates cytosolic [Ca2+], and inhibits phagocytosis in mouse macrophages.

Authors:  S S Sung; J D Young; A M Origlio; J M Heiple; H R Kaback; S C Silverstein
Journal:  J Biol Chem       Date:  1985-11-05       Impact factor: 5.157

2.  ATP4- permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes.

Authors:  T H Steinberg; A S Newman; J A Swanson; S C Silverstein
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.157

3.  Recombinant human gamma-interferon induces human monocyte polykaryon formation.

Authors:  J B Weinberg; M M Hobbs; M A Misukonis
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

4.  Extracellular ATP in T-lymphocyte activation: possible role in effector functions.

Authors:  A Filippini; R E Taffs; M V Sitkovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

5.  The ATP4- receptor of rat mast cells.

Authors:  S Cockcroft; B D Gomperts
Journal:  Biochem J       Date:  1980-06-15       Impact factor: 3.857

6.  Inhibition of human natural killer cell reactivity by exogenous adenosine 5'-triphosphate.

Authors:  A Schmidt; J R Ortaldo; R B Herberman
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

7.  Source and concentration of extracellular adenosine triphosphate during haemostasis in rats, rabbits and man.

Authors:  G V Born; M A Kratzer
Journal:  J Physiol       Date:  1984-09       Impact factor: 5.182

8.  Cyclic AMP inhibition of fMet-Leu-Phe-dependent metabolic responses in human neutrophils is not due to its effects on cytosolic Ca2+.

Authors:  P De Togni; G Cabrini; F Di Virgilio
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

9.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.

Authors:  S H Zigmond; J G Hirsch
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

10.  Interleukin 4 induces cultured monocytes/macrophages to form giant multinucleated cells.

Authors:  A McInnes; D M Rennick
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  65 in total

1.  ATP-induced Ca2+ response mediated by P2U and P2Y purinoceptors in human macrophages: signalling from dying cells to macrophages.

Authors:  Y Oshimi; S Miyazaki; S Oda
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

2.  ATP-induced [Ca(2+)](i) changes and depolarization in GH3 cells.

Authors:  H S Chung; K S Park; S K Cha; I D Kong; J W Lee
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

Review 3.  Pharmacology of P2X channels.

Authors:  Joel R Gever; Debra A Cockayne; Michael P Dillon; Geoffrey Burnstock; Anthony P D W Ford
Journal:  Pflugers Arch       Date:  2006-04-29       Impact factor: 3.657

4.  Oxidized ATP protection against anthrax lethal toxin.

Authors:  Mahtab Moayeri; Katherine E Wickliffe; Jason F Wiggins; Stephen H Leppla
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

5.  The endoplasmic reticulum (ER)-target protein Bik induces Hep3B cells apoptosis by the depletion of the ER Ca2+ stores.

Authors:  Xiaoping Zhao; Li Wang; Yan Sun; Ling Ye; Jian Lu; Yaozong Yuan; Guanxiang Qian; Shengfang Ge
Journal:  Mol Cell Biochem       Date:  2008-02-26       Impact factor: 3.396

6.  The role of P2 receptors in controlling infections by intracellular pathogens.

Authors:  Robson Coutinho-Silva; Cristiane Monteiro da Cruz; Pedro M Persechini; David M Ojcius
Journal:  Purinergic Signal       Date:  2007-01-12       Impact factor: 3.765

7.  Acute paw oedema formation induced by ATP: re-evaluation of the mechanisms involved.

Authors:  L E Ziganshina; A U Ziganshin; C H Hoyle; G Burnstock
Journal:  Inflamm Res       Date:  1996-02       Impact factor: 4.575

8.  Two different ionotropic receptors are activated by ATP in rat microglia.

Authors:  S Visentin; M Renzi; C Frank; A Greco; G Levi
Journal:  J Physiol       Date:  1999-09-15       Impact factor: 5.182

9.  Inhibition of P2X Receptors Protects Human Monocytes against Damage by Leukotoxin from Aggregatibacter actinomycetemcomitans and α-Hemolysin from Escherichia coli.

Authors:  Steen K Fagerberg; Martin R Jakobsen; Marianne Skals; Helle A Praetorius
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

10.  Generation of novel bone forming cells (monoosteophils) from the cathelicidin-derived peptide LL-37 treated monocytes.

Authors:  Zhifang Zhang; John E Shively
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.